Abstract

Stability Evaluation of Compounded Multidrug Oral Liquids in a Dual-Vehicle Suspending System

Author(s): Kegele Carolina Schettino, Taylor Sarah, Polonini Hudson

Issue: Jul/Aug 2026 - Volume 30, Number 4

Page(s): 379-391

Download in electronic PDF format for $75
  • Stability Evaluation of Compounded Multidrug Oral Liquids in a Dual-Vehicle Suspending System Page 1
  • Stability Evaluation of Compounded Multidrug Oral Liquids in a Dual-Vehicle Suspending System Page 2
  • Stability Evaluation of Compounded Multidrug Oral Liquids in a Dual-Vehicle Suspending System Page 3
  • Stability Evaluation of Compounded Multidrug Oral Liquids in a Dual-Vehicle Suspending System Page 4
  • Stability Evaluation of Compounded Multidrug Oral Liquids in a Dual-Vehicle Suspending System Page 5
  • Stability Evaluation of Compounded Multidrug Oral Liquids in a Dual-Vehicle Suspending System Page 6
  • Stability Evaluation of Compounded Multidrug Oral Liquids in a Dual-Vehicle Suspending System Page 7
  • Stability Evaluation of Compounded Multidrug Oral Liquids in a Dual-Vehicle Suspending System Page 8
  • Stability Evaluation of Compounded Multidrug Oral Liquids in a Dual-Vehicle Suspending System Page 9
  • Stability Evaluation of Compounded Multidrug Oral Liquids in a Dual-Vehicle Suspending System Page 10
  • Stability Evaluation of Compounded Multidrug Oral Liquids in a Dual-Vehicle Suspending System Page 11
  • Stability Evaluation of Compounded Multidrug Oral Liquids in a Dual-Vehicle Suspending System Page 12
  • Stability Evaluation of Compounded Multidrug Oral Liquids in a Dual-Vehicle Suspending System Page 13

Abstract

Extemporaneously compounded oral liquids are essential for patients unable to swallow solid dosage forms, although ensuring stability in aqueous systems remains challenging. This study evaluated the chemical, physical, and microbiological stability of formulations containing topiramate, omeprazole, gabapentin, ondansetron, and levofloxacin prepared in Flavor Sweet™ SF and Flavor Plus™, also known as Syra Sweet™ SF and Syra Plus™. Stability was assessed over 90 days at room temperature and under refrigeration using validated UHPLC methods, along with physical and microbiological analyses. Gabapentin, ondansetron, omeprazole, and topiramate remained stable for 90 days under both conditions, while levofloxacin was stable for 60 days at room temperature and 90 days refrigerated. All formulations showed consistent pH and acceptable microbiological quality, although precipitation in some samples led to discontinuation of analysis. These results support the suitability of the vehicle system and highlight the importance of formulation parameters in stability and beyond-use dating.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy
Title/Author
(Click for Abstract / Details / Purchase)
Jul/Aug 2026
Pg. 379-391
Jan/Feb 2003
Pg. 48-50
Author(s): Allen Loyd V Jr
May/Jun 2026
Pg. 269-285
Jan/Feb 2021
Pg. 73-81
May/Jun 2004
Pg. 181-185
Mar/Apr 1997
Pg. 90-92
Author(s): Allen Loyd V Jr
Nov/Dec 2017
Pg. 500-512
Mar/Apr 2003
Pg. 106-113
Author(s): Davidson Gigi S
Sep/Oct 2014
Pg. 427-431
Nov/Dec 2019
Pg. 504-510
Jul/Aug 2025
Pg. 319-327
May/Jun 2011
Pg. 255-258
Sep/Oct 2021
Pg. 431-439
May/Jun 2018
Pg. 240-246
Jul/Aug 2003
Pg. 313-319
Mar/Apr 2017
Pg. 164-170
Sep/Oct 2025
Pg. 409-419
Jan/Feb 2016
Pg. 81-85
Nov/Dec 2018
Pg. 480-489
Nov/Dec 2014
Pg. 456-460